Qingsong Liu
Affiliations: | Chinese Academic Science, High Magnetic Field Laboratory |
Area:
Translation medicineGoogle:
"Qingsong Liu"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhou B, Wang B, Zou F, et al. (2023) Discovery of dihydropyridinone derivative as a covalent EZH2 degrader. European Journal of Medicinal Chemistry. 261: 115825 |
| Hu C, Shen L, Zou F, et al. (2023) Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy. Acta Pharmaceutica Sinica. B. 13: 3694-3707 |
| Liang X, Deng M, Zou F, et al. (2023) Discovery of Pyrazolo[1,5-a]pyrimidine derivative as a potent and selective PI3Kγ/δ dual inhibitor. European Journal of Medicinal Chemistry. 260: 115768 |
| Liang Q, Wang B, Zou F, et al. (2023) Structure-based discovery of IHMT-IDH1-053 as a potent irreversible IDH1 mutant selective inhibitor. European Journal of Medicinal Chemistry. 256: 115411 |
| Wang A, Liu J, Li X, et al. (2023) Discovery of a highly potent pan-RAF inhibitor IHMT-RAF-128 for cancer treatment. European Journal of Pharmacology. 175752 |
| Guo C, Zhang L, Zhao M, et al. (2023) Targeting lipid metabolism with natural products: A novel strategy for gastrointestinal cancer therapy. Phytotherapy Research : Ptr |
| Mei H, Wu H, Yang J, et al. (2023) Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies. Signal Transduction and Targeted Therapy. 8: 18 |
| Wang ZW, Zou FM, Wang AL, et al. (2022) Repurposing of the FGFR inhibitor AZD4547 as a potent inhibitor of necroptosis by selectively targeting RIPK1. Acta Pharmacologica Sinica |
| Liang X, Wang C, Wang B, et al. (2022) Discovery of Pyrrolo[2,3-d]pyrimidine derivatives as potent and selective colony stimulating factor 1 receptor kinase inhibitors. European Journal of Medicinal Chemistry. 243: 114782 |
| Chen N, Qi Y, Ma X, et al. (2022) Rediscovery of Traditional Plant Medicine: An Underestimated Anticancer Drug of Chelerythrine. Frontiers in Pharmacology. 13: 906301 |